(Q84027945)
Statements
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis (English)
Bradley J Monk
Thomas J Herzog
Stanley B Kaye
Carolyn N Krasner
Jan B Vermorken
Eric Pujade-Lauraine
Youn C Park
Trilok V Parekh
Andres M Poveda